HOME › DRUGS › EMTRICITABINE;RILPIVIRINE;TENOFOVIR ALAFENAMIDE
ACTIVE SUBSTANCE / INN

EMTRICITABINE;RILPIVIRINE;TENOFOVIR ALAFENAMIDE

Brand name(s): Odefsey, Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris
EMA LISTED
AUTHORISED
HIV Infections
ACTIVE SUBSTANCE
Emtricitabine;Rilpivirine;Tenofovir Alafenamide
REGULATORS
EMA
SPONSORS / MAH
Gilead Sciences Ireland UC, Viatris Limited
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Emtricitabine / Rilpivirine / Tenofovir Alafenamide ViatrisViatris LimitedAuthorised19/08/2025HIV Infections
OdefseyGilead Sciences Ireland UCAuthorised21/06/2016HIV Infections

FULL INTELLIGENCE ON EMTRICITABINE;RILPIVIRINE;TENOFOVIR ALAFENAMIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →